Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma

NCT03938012 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT03938012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03938012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma
Lead sponsor
National University Hospital, Singapore
Phase
Observational
Overall status
Unknown status
Start date
October 3, 2017
Completion date
October 31, 2022
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of the head and neck, squamous cell carcinoma of the lung